▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
April 20, 2024

Market Now

Access Bio acquires patent for G6PD deficiency diagnosis technology

  • PUBLISHED :January 11, 2017 - 15:51
  • UPDATED :January 11, 2017 - 15:51
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[DISCLOSURE] Access Bio (950130) announced on Jan. 11 that it has acquired a patent in the US for an improved technology related to diagnosis of G6PD deficiency, a hereditary blood disease.

(theinvestor@heraldcorp.com)

BACK TO LIST TOP

EDITOR'S PICKS

  • 인스타그램
Herald Corporation |CEO : Jeon Chang-hyeop |Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea |Title : The Investor |Date of registration : 2016.06.21 |Date of issue : 2016.06.21
Publisher. Editor : Shin Yong-bae |Chief Privacy Officer & Juvenile Protection Manager : Shin Yong-bae |T +82-2-727-0021 |E investor@heraldcorp.com
FAMILY SITE GO

Company Registration No. 104-81-06004 |Mail-Order Business Registration 2016 - Seoul Yongsan - 00590 |Business info |Gov’t registration No. Seoul 아04099